80 related articles for article (PubMed ID: 12928477)
1. siRNA Therapeutics: Future Promise for Neurodegenerative Diseases.
Amiri A; Barreto G; Sathyapalan T; Sahebkar A
Curr Neuropharmacol; 2021; 19(11):1896-1911. PubMed ID: 33797386
[TBL] [Abstract][Full Text] [Related]
2. RNA therapeutics for neurological disease.
Nguyen L
Prog Mol Biol Transl Sci; 2024; 203():165-180. PubMed ID: 38359997
[TBL] [Abstract][Full Text] [Related]
3. Cellular Targeting of Oligonucleotides by Conjugation with Small Molecules.
Hawner M; Ducho C
Molecules; 2020 Dec; 25(24):. PubMed ID: 33339365
[TBL] [Abstract][Full Text] [Related]
4. Targeting caspase-3 as dual therapeutic benefits by RNAi facilitating brain-targeted nanoparticles in a rat model of Parkinson's disease.
Liu Y; Guo Y; An S; Kuang Y; He X; Ma H; Li J; Lu J; Zhang N; Jiang C
PLoS One; 2013; 8(5):e62905. PubMed ID: 23675438
[TBL] [Abstract][Full Text] [Related]
5. Assessment of allele-specific gene silencing by RNA interference with mutant and wild-type reporter alleles.
Ohnishi Y; Tokunaga K; Kaneko K; Hohjoh H
J RNAi Gene Silencing; 2006 Feb; 2(1):154-60. PubMed ID: 19771217
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Rho-GDI gamma promotes differentiation of neural stem cells.
Lu W; Wang J; Wen T
Mol Cell Biochem; 2008 Apr; 311(1-2):233-40. PubMed ID: 18273563
[TBL] [Abstract][Full Text] [Related]
7. Modulating the expression of disease genes with RNA-based therapy.
Wood M; Yin H; McClorey G
PLoS Genet; 2007 Jun; 3(6):e109. PubMed ID: 17604456
[TBL] [Abstract][Full Text] [Related]
8. RNA interference in neuroscience: progress and challenges.
Miller VM; Paulson HL; Gonzalez-Alegre P
Cell Mol Neurobiol; 2005 Dec; 25(8):1195-207. PubMed ID: 16388332
[TBL] [Abstract][Full Text] [Related]
9. An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons.
Luo MC; Zhang DQ; Ma SW; Huang YY; Shuster SJ; Porreca F; Lai J
Mol Pain; 2005 Sep; 1():29. PubMed ID: 16191203
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic potential of RNA interference.
Uprichard SL
FEBS Lett; 2005 Oct; 579(26):5996-6007. PubMed ID: 16115631
[TBL] [Abstract][Full Text] [Related]
11. RNA interference technologies for understanding and treating neurodegenerative diseases.
Lu B
Neuromolecular Med; 2004; 6(1):1-12. PubMed ID: 15781973
[TBL] [Abstract][Full Text] [Related]
12. RNA interference and its current application in mammals.
Shen WG
Chin Med J (Engl); 2004 Jul; 117(7):1084-91. PubMed ID: 15265387
[TBL] [Abstract][Full Text] [Related]
13. RNA interference for the identification of disease-associated genes.
Nencioni A; Sandy P; Dillon C; Kissler S; Blume-Jensen P; Van Parijs L
Curr Opin Mol Ther; 2004 Apr; 6(2):136-40. PubMed ID: 15195924
[TBL] [Abstract][Full Text] [Related]
14. Short interfering RNA (siRNA): tool or therapeutic?
Cejka D; Losert D; Wacheck V
Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204
[TBL] [Abstract][Full Text] [Related]
15. RNA interference: potential therapeutic targets.
Jana S; Chakraborty C; Nandi S; Deb JK
Appl Microbiol Biotechnol; 2004 Nov; 65(6):649-57. PubMed ID: 15372214
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic gene silencing in the nervous system.
Wood MJ; Trülzsch B; Abdelgany A; Beeson D
Hum Mol Genet; 2003 Oct; 12 Spec No 2():R279-84. PubMed ID: 12928477
[TBL] [Abstract][Full Text] [Related]
17. Ribozymes and siRNA for the treatment of diseases of the nervous system.
Wood MJ; Trülzsch B; Abdelgany A; Beeson D
Curr Opin Mol Ther; 2003 Aug; 5(4):383-8. PubMed ID: 14513681
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
